Literature DB >> 28882932

Hickam's dictum: Myasthenia Gravis presenting concurrently with Graves' disease.

Shekhar Sehgal1, Roshan Rebello1, Louise Wolmarans1, Marianne Elston1,1.   

Abstract

We present two patients with Graves' disease and concurrent myasthenia gravis. The impact of the dual diagnosis on the clinical course and the potential for a delayed diagnosis of myasthenia gravis is discussed. Patient 1, a 28-year-old man was diagnosed with Graves' disease following his second respiratory arrest. His history was strongly suggestive of a second pathology. Patient 2, a 66-year-old Cantonese woman with established Graves' disease presented with thionamide-related neutropaenia. Examination revealed bilateral ptosis and right lateral rectus palsy. Both patients had thyrotoxicosis secondary to Graves' disease with concurrent myasthenia gravis. Although neuromuscular weakness is common in Graves' disease, coexisting myasthenia gravis (MG) is rare and can cause profound morbidity. Ocular signs in both diseases may cause diagnostic confusion although ptosis suggests coexisting MG. In both cases, the thyrotoxicosis delayed the diagnosis of MG. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  muscle disease; thyroid disease

Mesh:

Substances:

Year:  2017        PMID: 28882932      PMCID: PMC5589050          DOI: 10.1136/bcr-2017-220153

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  24 in total

1.  Increased frequency of euthyroid ophthalmopathy in patients with Graves' disease associated with myasthenia gravis.

Authors:  M Marinò; G Barbesino; A Pinchera; L Manetti; R Ricciardi; B Rossi; A Muratorio; L E Braverman; S Mariotti; L Chiovato
Journal:  Thyroid       Date:  2000-09       Impact factor: 6.568

2.  Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis.

Authors:  Atsushi Watanabe; Toshiaki Watanabe; Takuro Obama; Tohru Mawatari; Hisayoshi Ohsawa; Yasunori Ichimiya; Noriyuki Takahashi; Katsuyuki Kusajima; Tomio Abe
Journal:  J Thorac Cardiovasc Surg       Date:  2004-03       Impact factor: 5.209

Review 3.  Thyrotoxic periodic paralysis.

Authors:  Shih-Hua Lin
Journal:  Mayo Clin Proc       Date:  2005-01       Impact factor: 7.616

4.  Reverse 'see-saw' relationship between Graves' disease and myasthenia gravis; clinical and immunological studies.

Authors:  Yoshihiro Sekiguchi; Yoshihito Hara; Mafuyu Takahashi; Yukio Hirata
Journal:  J Med Dent Sci       Date:  2005-03

5.  Exacerbation of myasthenia gravis shortly after administration of methimazole for hyperthyroidism.

Authors:  Y Kuroda; C Endo; R Neshige; R Kakigi
Journal:  Jpn J Med       Date:  1991 Nov-Dec

6.  The association of grave's disease with myasthenia gravis, with a report of five cases.

Authors:  G LEVY; W R MEADOWS; R M GUNNAR
Journal:  Ann Intern Med       Date:  1951-07       Impact factor: 25.391

Review 7.  Anaesthesia and myasthenia gravis.

Authors:  A Baraka
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

8.  A prospective assessment of the characteristics of dysphagia in myasthenia gravis.

Authors:  Angela Colton-Hudson; Wilma J Koopman; Taslim Moosa; Dean Smith; David Bach; Michael Nicolle
Journal:  Dysphagia       Date:  2002       Impact factor: 3.438

9.  Concurrent Graves disease thyrotoxicosis and myasthenia gravis: the treatment of the former may dangerously reveal the latter.

Authors:  K Lakhal; Y Blel; M Fysekidis; K Mohammedi; L Bouadma
Journal:  Anaesthesia       Date:  2008-06-02       Impact factor: 6.955

10.  Thyrotoxic, hypokalaemic periodic paralysis: Polynesians, an ethnic group at risk.

Authors:  M S Elston; B J Orr-Walker; A M Dissanayake; J V Conaglen
Journal:  Intern Med J       Date:  2007-05       Impact factor: 2.048

View more
  1 in total

1.  Rare concurrent ocular myasthenia gravis and Graves' ophthalmopathy in a man with Poland syndrome: a case report.

Authors:  Jingqun Tang; Chao Qin
Journal:  BMC Neurol       Date:  2020-12-10       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.